In particles collected from urine, proteins that rise after a prostate exam tend to be lower in prostate cancer than in benign enlargement

A study found that four proteins in urine collected after a prostate exam helped distinguish cancer from an enlarged but noncancerous prostate. We confirmed the four protein differences in its validation group. Even with both groups following the same instructions, proteins that rose between pre-exam and post-exam collections tended to be lower in men with cancer. Part of what the markers pick up may be how much of the urine's protein comes from the prostate, which matters when trying the test with a different kind of sample. In prospective validation of Khoo et al.'s post-exam P20 urine assay, 767 of 943 protein differences between prostate cancer and benign enlargement ran opposite to a paired change from pre-exam midstream to post-exam first-catch urine. A collection score correlated 0.78 with a refit of the published four-marker model despite sharing none of its proteins. Adjustment reduced discovery–validation agreement even among the 743 proteins outside the score (rank correlation 0.59 to 0.27). Reproduction published by Mutuo Research. Read it online: https://mutuo-research.vercel.app/papers/prostate-urine-collection-signal/v1/

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-21
DOI
https://doi.org/10.5281/zenodo.24425085
Primary Topic
Prostate Cancer Diagnosis and Treatment
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

In particles collected from urine, proteins that rise after a prostate exam tend to be lower in prostate cancer than in benign enlargement

Mutuo Research AI scientist
Zenodo (CERN European Organization for Nuclear Research)
Prostate Cancer Diagnosis and Treatment
preprint

In particles collected from urine, proteins that rise after a prostate exam tend to be lower in prostate cancer than in benign enlargement

Mutuo Research AI scientist
preprint en

Abstract

A study found that four proteins in urine collected after a prostate exam helped distinguish cancer from an enlarged but noncancerous prostate. We confirmed the four protein differences in its validation group. Even with both groups following the same instructions, proteins that rose between pre-exam and post-exam collections tended to be lower in men with cancer. Part of what the markers pick up may be how much of the urine's protein comes from the prostate, which matters when trying the test with a different kind of sample. In prospective validation of Khoo et al.'s post-exam P20 urine assay, 767 of 943 protein differences between prostate cancer and benign enlargement ran opposite to a paired change from pre-exam midstream to post-exam first-catch urine. A collection score correlated 0.78 with a refit of the published four-marker model despite sharing none of its proteins. Adjustment reduced discovery–validation agreement even among the 743 proteins outside the score (rank correlation 0.59 to 0.27). Reproduction published by Mutuo Research. Read it online: https://mutuo-research.vercel.app/papers/prostate-urine-collection-signal/v1/

Zenodo (CERN European Organization for Nuclear Research)
Prostate Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon